The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications

Bibliography

• Klingenberg M. Pigments of rat liver microsomes. Arch Biochem Biophys 1958;75(2):376-86
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. A new cytochrome in liver microsomes. J Biol Chem 1962;237(4):PC1375-PC76
   Google Scholar
• Munro AW, Girvan HM, McLean KJ. Variations on a (t)heme - novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat Prod Rep 2007;24(3):585
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Tang Z, Cheng Q, et al. Approaches to deorphanization of human and microbial cytochrome P450 enzymes. Biochim Biophys Acta 2011;1814(1):139-45
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6(12):947-60
   PubMed Web of Science ®Google Scholar
• Paine MF, Hart HL, Ludington SS, et al. The human intestinal cytochrome P450 ‘pie'. Drug Metab Dispos 2006;34(5):880-6
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 2004;34(7):633-64
   PubMed Web of Science ®Google Scholar
• Nelson DR. Progress in tracing the evolutionary paths of cytochrome P450. Biochim Biophys Acta 2011;1814(1):14-18
   PubMed Web of Science ®Google Scholar
• Nelson DR, Goldstone JV, Stegeman JJ. The cytochrome P450 genesis locus: the origin and evolution of animal cytochrome P450s. Philos Trans R Soc Lond: B Biol Sci 2013;368(1612):20120474
   PubMed Web of Science ®Google Scholar
• Werck-Reichhart D, Feyereisen R. Cytochromes P450: a success story. Genome Biol 2000;1(6):1-9
   PubMedGoogle Scholar
• Nelson DR. Cytochrome P450 and the individuality of species. Arch Biochem Biophys 1999;369(1):1-10
   PubMed Web of Science ®Google Scholar
• Gotoh O. Evolution of cytochrome p450 genes from the viewpoint of genome informatics. Biol Pharm Bull 2012;35(6):812-17
   PubMed Web of Science ®Google Scholar
• Markov GV, Tavares R, Dauphin-Villemant C, et al. Independent elaboration of steroid hormone signaling pathways in metazoans. Proc Natl Acad Sci USA 2009;106(29):11913-18
   PubMed Web of Science ®Google Scholar
• Foti RS, Honaker M, Nath A, et al. Catalytic versus inhibitory promiscuity in cytochrome P450s: implications for evolution of new function. Biochemistry 2011;50(13):2387-93
   PubMed Web of Science ®Google Scholar
• Thomas JH. Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet 2007;3(5):e67
   PubMed Web of Science ®Google Scholar
• Denisov IG, Makris TM, Sligar SG, et al. Structure and chemistry of cytochrome P450. Chem Rev 2005;105(6):2253-77
   PubMed Web of Science ®Google Scholar
• Munro AW, Lindsay JG. Bacterial cytochromes P-450. Mol Microbiol 1996;20(6):1115-25
   PubMed Web of Science ®Google Scholar
• Nagy I, Compernolle F, Ghys K, et al. A single cytochrome P-450 system is involved in degradation of the herbicides EPTC (S-ethyl dipropylthiocarbamate) and atrazine by Rhodococcus sp. strain NI86/21. Appl Environ Microbiol 1995;61(5):2056-60
   PubMed Web of Science ®Google Scholar
• Hudson SA, McLean KJ, Munro AW, et al. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets. Biochem Soc Trans 2012;40(3):573-9
   PubMedGoogle Scholar
• McLean KJ, Clift D, Lewis DG, et al. The preponderance of P450s in the Mycobacterium tuberculosis genome. Trends Microbiol 2006;14(5):220-8
   PubMed Web of Science ®Google Scholar
• McLean KJ, Munro AW. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. Drug Metab Rev 2008;40(3):427-46
   PubMed Web of Science ®Google Scholar
• Stewart GR, Wernisch L, Stabler R, et al. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 2002;148(10):3129-38
   PubMedGoogle Scholar
• Driscoll MD, McLean KJ, Cheesman MR, et al. Expression and characterization of Mycobacterium tuberculosis CYP144: Common themes and lessons learned in the M. tuberculosis P450 enzyme family. Biochim Biophys Acta 2011;1814(1):76-87
   PubMed Web of Science ®Google Scholar
• Ning D, Wang H. Involvement of cytochrome P450 in pentachlorophenol transformation in a white rot fungus Phanerochaete chrysosporium. PLoS ONE 2012;7(9):e45887
   PubMed Web of Science ®Google Scholar
• Ichinose H. Molecular and functional diversity of fungal cytochrome P450s. Biol Pharm Bull 2012;35(6):833-7
   PubMed Web of Science ®Google Scholar
• Črešnar B, Petrič Š. Cytochrome P450 enzymes in the fungal kingdom. Biochim Biophys Acta 2011;1814(1):29-35
   PubMed Web of Science ®Google Scholar
• Perrin RM, Fedorova ND, Bok JW, et al. Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA. PLoS Pathog 2007;3(4):e50
   PubMedGoogle Scholar
• Koo AJK, Cooke TF, Howe GA. Cytochrome P450 CYP94B3 mediates catabolism and inactivation of the plant hormone jasmonoyl-L-isoleucine. Proc Natl Acad Sci USA 2011;108(22):9298-303
   PubMed Web of Science ®Google Scholar
• Nelson D, Werck-Reichhart D. A P450-centric view of plant evolution. Plant J 2011;66(1):194-211
   PubMed Web of Science ®Google Scholar
• Iga M, Kataoka H. Recent studies on insect hormone metabolic pathways mediated by cytochrome P450 enzymes. Biol Pharm Bull 2012;35(6):838-43
   PubMed Web of Science ®Google Scholar
• Ohnishi T, Yokota T, Mizutani M. Insights into the function and evolution of P450s in plant steroid metabolism. Phytochemistry 2009;70(17-18):1918-29
   PubMed Web of Science ®Google Scholar
• Qi X, Bakht S, Qin B, et al. A different function for a member of an ancient and highly conserved cytochrome P450 family: from essential sterols to plant defense. Proc Natl Acad Sci USA 2006;103(49):18848-53
   PubMed Web of Science ®Google Scholar
• Field B, Osbourn AE. Metabolic diversification - independent assembly of operon-like gene clusters in different plants. Science 2008;320(5875):543-7
   PubMed Web of Science ®Google Scholar
• Qi X, Bakht S, Leggett M, et al. A gene cluster for secondary metabolism in oat: implications for the evolution of metabolic diversity in plants. Proc Natl Acad Sci USA 2004;101(21):8233-8
   PubMed Web of Science ®Google Scholar
• Mizutani M. Impacts of diversification of cytochrome P450 on plant metabolism. Biol Pharm Bull 2012;35(6):824-32
   PubMed Web of Science ®Google Scholar
• Harrison RM, Hester RE. editors. Chlorinated organic micropollutants. Royal Society of Chemistry; Great Britian: 1995
   Google Scholar
• Feyereisen R. Arthropod CYPomes illustrate the tempo and mode in P450 evolution. Biochim Biophys Acta 2011;1814(1):19-28
   PubMed Web of Science ®Google Scholar
• Goldstone JV, McArthur AG, Kubota A, et al. Identification and developmental expression of the full complement of cytochrome P450 genes in Zebrafish. BMC Genomics 2010;11:643
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shiro Y. Diversity and substrate specificity in the structures of steroidogenic cytochrome P450 enzymes. Biol Pharm Bull 2012;35(6):818-23
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28(1):235-42
   PubMed Web of Science ®Google Scholar
• Munro AW, Girvan HM, Mason AE, et al. What makes a P450 tick? Trends Biochem Sci 2013;38(3):140-50
   PubMed Web of Science ®Google Scholar
• McLean KJ, Girvan HM, Munro AW. Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects. Expert Opin Drug Metab Toxicol 2007;3(6):847-63
   PubMed Web of Science ®Google Scholar
• Rittle J, Green MT. Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics. Science 2010;330(6006):933-7
   PubMed Web of Science ®Google Scholar
• Shakunthala N. New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochrome. Expert Opin Drug Metab Toxicol 2010;6(1):1-15
   PubMed Web of Science ®Google Scholar
• Sansen S, Yano JK, Reynald RL, et al. Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 2007;282(19):14348-55
   PubMed Web of Science ®Google Scholar
• Denisov IG, Shih AY, Sligar SG. Structural differences between soluble and membrane bound cytochrome P450s. J Biochem 2012;108:150-8
   Web of Science ®Google Scholar
• Jiang W, Ghosh D. Motion and flexibility in human cytochrome P450 aromatase. PLoS One 2012;7(2):e32565
   PubMedGoogle Scholar
• Munro AW, Leys DG, McLean KJ, et al. P450 BM3: the very model of a modern flavocytochrome. Trends Biochem Sci 2002;27(5):250-7
   PubMed Web of Science ®Google Scholar
• Praporski S, Ng SM, Nguyen AD, et al. Organization of cytochrome P450 enzymes involved in sex steroid synthesis: Protein-protein interactions in lipid membranes. J Biol Chem 2009;284(48):33224-32
   PubMed Web of Science ®Google Scholar
• Davydov DR. Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions. Expert Opin Drug Metab Toxicol 2011;7(5):543-58
   PubMed Web of Science ®Google Scholar
• Denisov IG, Frank DJ, Sligar SG. Cooperative properties of cytochromes P450. Pharmacol Ther 2009;124(2):151-67
   PubMed Web of Science ®Google Scholar
• Davydov DR, Halpert JR. Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both? Expert Opin Drug Metab Toxicol 2008;4(12):1523-35
   PubMed Web of Science ®Google Scholar
• Idkowiak J, Randell T, Dhir V, et al. A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab 2012;97(3):E465-75
   PubMed Web of Science ®Google Scholar
• Hershkovitz E, Parvari R, Wudy SA, et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 2008;93(9):3584-8
   PubMed Web of Science ®Google Scholar
• Jushchyshyn MI, Hutzler JM, Schrag ML, et al. Catalytic turnover of pyrene by CYP3A4: evidence that cytochrome b5 directly induces positive cooperativity. Arch Biochem Biophys 2005;438(1):21-8
   PubMed Web of Science ®Google Scholar
• Voice MW, Zhang Y, Wolf CR, et al. Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo. Arch Biochem Biophys 1999;366(1):116-24
   PubMed Web of Science ®Google Scholar
• Pudney CR, Heyes DJ, Khara B, et al. Kinetic and spectroscopic probes of motions and catalysis in the cytochrome P450 reductase family of enzymes. FEBS J 2012;279(9):1534-44
   PubMed Web of Science ®Google Scholar
• Leferink NG, Pudney CR, Brenner S, et al. Gating mechanisms for biological electron transfer: integrating structure with biophysics reveals the nature of redox control in cytochrome P450 reductase and copper-dependent nitrite reductase. FEBS Lett 2012;586(5):578-84
   PubMed Web of Science ®Google Scholar
• Lin JH. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 2006;23(6):1089-116
   PubMed Web of Science ®Google Scholar
• Corcos L, Lucas D, Le Jossic-Corcos C, et al. Human cytochrome P450 4F3: structure, functions, and prospects. Drug Metabol Drug Interact 2012;27(2):63-71
   PubMedGoogle Scholar
• Peer CJ, Sissung TM, Figg WD. CHIP and gp78-mediated ubiquitination of CYP3A4: implications for the pharmacology of anticancer agents. Cancer Biol Ther 2011;11(6):549-51
   PubMed Web of Science ®Google Scholar
• Pabarcus MK, Hoe N, Sadeghi S, et al. CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys 2009;483(1):66-74
   PubMed Web of Science ®Google Scholar
• Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11(16):5793-801
   PubMed Web of Science ®Google Scholar
• GajjarK Martin-Hirsch PL, Martin FL. CYP1B1 and hormone-induced cancer. Cancer Lett 2012;324(1):13-30
   PubMed Web of Science ®Google Scholar
• Jin M, Kumar A, Kumar S. Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: role of oxidative stress-mediated PKC/MEK/Nrf2 pathway. PLoS ONE 2012;7(4):e35505
   Google Scholar
• Sinz M, Wallace G, Sahi J. Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS Journal 2008;10(2):391-400
   PubMed Web of Science ®Google Scholar
• Lee S, Kim D. Cytochrome P450 networks in chemical space. Arch Pharm Res 2010;33(9):1361-74
   PubMed Web of Science ®Google Scholar
• Goldstone JV, Goldstone HM, Morrison AM, et al. Cytochrome P450 1 genes in early deuterostomes (tunicates and sea urchins) and vertebrates (chicken and frog): origin and diversification of the CYP1 gene family. Mol Biol Evol 2007;24(12):2619-31
   PubMed Web of Science ®Google Scholar
• Kawajiri K, Fujii-Kuriyama Y. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys 2007;464(2):207-12
   PubMed Web of Science ®Google Scholar
• Mitchell KA, Elferink CJ. Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol 2009;77(6):947-56
   PubMed Web of Science ®Google Scholar
• Jorge-Nebert LF, Jiang Z, Chakraborty R, et al. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Hum Mutat 2010;31(1):27-40
   PubMed Web of Science ®Google Scholar
• Ueda R, Iketaki H, Nagata K, et al. A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol 2006;69(6):1924-30
   PubMed Web of Science ®Google Scholar
• Zhou H, Qu Y, Wu H, et al. Molecular phylogenies and evolutionary behavior of AhR (aryl hydrocarbon receptor) pathway genes in aquatic animals: implications for the toxicology mechanism of some persistent organic pollutants (POPs). Chemosphere 2010;78(2):193-205
   PubMed Web of Science ®Google Scholar
• Uno T, Ishizuka M, Itakura T. Cytochrome P450 (CYP) in fish. Environ Toxicol Pharmacol 2012;34(1):1-13
   PubMed Web of Science ®Google Scholar
• Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 2009;9:187
   PubMed Web of Science ®Google Scholar
• Braeuning A, Kohle C, Buchmann A, et al. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway. Toxicol Sci 2011;122(1):16-25
   PubMed Web of Science ®Google Scholar
• OhtakeF Fujii-Kuriyama Y, Kawajiri K, et al. Cross-talk of dioxin and estrogen receptor signals through the ubiquitin system. J Steroid Biochem Mol Biol 2011;127(1-2):102-7
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Kyo S, et al. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004;64(9):3119-25
   PubMed Web of Science ®Google Scholar
• Rataj F, Moller FJ, Jahne M, et al. Regulation of uterine AHR battery gene expression by 17beta-Estradiol is predominantly mediated by estrogen receptor alpha. Arch Toxicol 2012;86(10):1603-12
   PubMed Web of Science ®Google Scholar
• Tarnow P, Tralau T, Hunecke D, et al. Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells. Toxicol in Vitro 2013;27(5):1467-75
   PubMed Web of Science ®Google Scholar
• Lim YP, Huang JD. Interplay of pregnane X receptor with other nuclear receptors on gene regulation. Drug Metab Pharmacokinet 2008;23(1):14-21
   PubMed Web of Science ®Google Scholar
• Pan Y-Z, Gao W, Yu A-M. MicroRNAs regulate CYP3A4 expression via direct and indirecttargeting. Drug Metab Dispos 2009;37(10):2112-17
   PubMed Web of Science ®Google Scholar
• Jennewein C, von Knethen A, Schmid T, et al. microRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 2010;285(16):11846-53
   PubMed Web of Science ®Google Scholar
• Karbiener M, Fischer C, Nowitsch S, et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ. Biochem Biophys Res Commun 2009;390(2):247-51
   PubMed Web of Science ®Google Scholar
• Dong H, Lin W, Wu J, et al. Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochem 2010;11:23-32
   PubMed Web of Science ®Google Scholar
• Munro AW, Girvan HM, McLean KJ. Cytochrome P450 - redox partner fusion enzymes. Biochim Biophys Acta 2007;1770(3):345-59
   PubMed Web of Science ®Google Scholar
• Patel JP, Brocks DR. The effect of oral lipids and circulating lipoproteins on the metabolism of drugs. Expert Opin Drug Metab Toxicol 2009;5(11):1385-98
   PubMed Web of Science ®Google Scholar
• Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 2011;1814(1):186-99
   PubMed Web of Science ®Google Scholar
• Klein K, Zanger UM. Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem. Front Genet 2013;4:12
   PubMedGoogle Scholar
• Wang H, Tompkins LM. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metabol 2008;9(7):598-610
   PubMed Web of Science ®Google Scholar
• Baker ME. Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors. Mol Cell Endocrinol 2011;334(1-2):14-20
   PubMed Web of Science ®Google Scholar
• Zhu BT. On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations. Expert Opin Drug Metab Toxicol 2010;6(4):483-94
   PubMed Web of Science ®Google Scholar
• Bulun SE, Chen D, Moy I, et al. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 2012;23(2):83-9
   PubMed Web of Science ®Google Scholar
• Schults MA, Timmermans L, Godschalk RW, et al. Diminished carcinogen detoxification is a novel mechanism for hypoxia-inducible factor 1-mediated genetic instability. J Biol Chem 2010;285(19):14558-64
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Takagi S, et al. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 2006;66(18):9090-8
   PubMed Web of Science ®Google Scholar
• Bookout AL, Jeong Y, Downes M, et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126(4):789-99
   PubMed Web of Science ®Google Scholar
• Stocco C. Tissue physiology and pathology of aromatase. Steroids 2012;77(1-2):27-35
   PubMed Web of Science ®Google Scholar
• Henkler F, Stolpmann K, Luch A. Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses. EXS 2012;101:107-31
   PubMedGoogle Scholar
• Stolpmann K, Brinkmann J, Salzmann S, et al. Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis. Cell Death Dis 2012;3:e388
   PubMedGoogle Scholar
• Rezen T, Rozman D, Pascussi J-M, et al. Interplay between cholesterol and drug metabolism. Biochim Biophys Acta 2011;1814(1):146-60
   PubMed Web of Science ®Google Scholar
• McLean KJ, Hans M, Munro AW. Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes. Biochem Soc Trans 2012;40(3):587-93
   PubMedGoogle Scholar
• Lutz JD, Isoherranen N. In vitro-to-in vivo predictions of drug-drug interactions involving multiple reversible inhibitors. Expert Opin Drug Metab Toxicol 2012;8(4):449-66
   PubMed Web of Science ®Google Scholar
• Tralau T. Luch A. “Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology. Expert Opin Drug Metab Toxicol 2012;8(11):1357-62
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013;138(1):103-41
   PubMed Web of Science ®Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin Pharmacokinet 2009;48(11):689-723
   PubMed Web of Science ®Google Scholar
• Bansal S, Anandatheerthavarada HK, Prabu GK, et al. Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models. J Biol Chem 2013;288(18):12627-44
   PubMed Web of Science ®Google Scholar
• Sadee W, Wang D, Papp AC, et al. Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin Pharmacol Ther 2011;89(3):355-65
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab Pharmacokinet 2011;26(1):3-14
   PubMed Web of Science ®Google Scholar
• Cali JJ, Ma D, Wood MG, et al. Bioluminescent assays for ADME evaluation: dialing in CYP selectivity with luminogenic substrates. Expert Opin Drug Metab Toxicol 2012;8(9):1115-30
   PubMed Web of Science ®Google Scholar
• Kumar S. Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation. Expert Opin Drug Metab Toxicol 2010;6(2):115-31
   PubMed Web of Science ®Google Scholar
• Tralau T, Luch A. Drug-mediated toxicity: illuminating the ‘bad' in the test tube by means of cellular assays? Trends Pharmacol Sci 2012;33(7):353-64
   PubMed Web of Science ®Google Scholar
• Bruno RD, Njar VC. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem 2007;15(15):5047-60
   PubMed Web of Science ®Google Scholar
• Chumsri S, Howes T, Bao T, et al. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 2011;125(1-2):13-22
   PubMed Web of Science ®Google Scholar
• Ghosh D, Lo J, Morton D, et al. Novel aromatase inhibitors by structure-guided design. J Med Chem 2012;55(19):8464-76
   PubMed Web of Science ®Google Scholar
• Sabnis G, Goloubeva O, Jelovac D, et al. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens. Clin Cancer Res 2007;13(9):2751-7
   PubMed Web of Science ®Google Scholar
• Walsh AA, Szklarz GD, Scott EE. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 2013;288(18):12932-43
   PubMed Web of Science ®Google Scholar
• Attard G, Belldegrun AS, de Bono JS. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU Int 2005;96(9):1241
   PubMed Web of Science ®Google Scholar
• Bedoya DJ, Mitsiades N. Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions. Onco Targets Ther 2013;6:9-18
   PubMed Web of Science ®Google Scholar
• de Vore NM, Scott EE. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. Nature 2012;482(7383):116
   PubMed Web of Science ®Google Scholar
• Chen Y, Clegg NJ, Scher HI. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol 2009;10(10):981
   PubMed Web of Science ®Google Scholar
• Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 2009;8(10):794-805
   PubMed Web of Science ®Google Scholar
• Guo AM, Arbab AS, Falck JR, et al. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 2007;321(1):18-27
   PubMed Web of Science ®Google Scholar
• Ljubimov AV, Grant MB. P450 in the angiogenesis affair: the unusual suspect. Am J Pathol 2005;166(2):341-4
   PubMed Web of Science ®Google Scholar
• Jiang M, Mezentsev A, Kemp R, et al. Smooth muscle - specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. Circ Res 2004;94(2):167-74
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Kaipainen A, Greene ER, et al. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev 2010;29(4):723-35
   PubMed Web of Science ®Google Scholar
• Preissner S, Dunkel M, Hoffmann MF, et al. Drug cocktail optimization in chemotherapy of cancer. PLoS One 2012;7(12):e51020
   PubMedGoogle Scholar
• Narayan ARH, Sherman DH. Re-engineering nature's catalysts. Science 2013;339(6117):283-4
   PubMed Web of Science ®Google Scholar
• Landwehr M, Hochrein L, Otey CR, et al. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. J Am Chem Soc 2006;128(18):6058-9
   PubMed Web of Science ®Google Scholar
• Bistolas N, Wollenberger U, Jung C, et al. Cytochrome P450 biosensors-a review. Biosens Bioelectron 2005;20(12):2408-23
   PubMed Web of Science ®Google Scholar
• Caswell JM, O'Neill M, Taylor SJ, Moody TS. Engineering and application of P450 monooxygenases in pharmaceutical and metabolite synthesis. Curr Opin Chem Biol 2013;17(2):271-5
   PubMed Web of Science ®Google Scholar
• Dietrich JA, Yoshikuni Y, Fisher KJ, et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chem Biol 2009;4(4):261-7
   PubMed Web of Science ®Google Scholar
• Sakaki T. Practical application of cytochrome P450. Biol Pharm Bull 2012;35(6):844-49
   PubMed Web of Science ®Google Scholar
• Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29(6):726-76
   PubMed Web of Science ®Google Scholar
• Wang TT, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005;19(11):2685-95
   PubMed Web of Science ®Google Scholar
• Singh D, Kashyap A, Pandey RV, et al. Novel advances in cytochrome P450 research. Drug Discov Today 2011;16(17-18):793-9
   PubMed Web of Science ®Google Scholar